Sino white Industrial Park signed letter of intent with pianzi Huang pharmaceutical, CAMCE international and Jintai Academy of culture

发布于: 2021-06-10 00:00

 

On June 10, the signing ceremony of letter of intent between Zhongbai Industrial Park and Zhangzhou Pianzihuang Pharmaceutical Co., Ltd. (hereinafter referred to as "Pianzihuang pharmaceutical"), CAMCE International Engineering Co., Ltd. (hereinafter referred to as "CAMCE") and Jintai Academy of culture was successfully held in Zhangzhou.

 

Yan Gang, general manager of China Belarus Industrial Park, signed a letter of intent on cooperation with Pan Jie, chairman of Pianzihuang pharmaceutical, Wang Yuhang, general manager of CAMCE, and Cai Chuanqing, President of Jintai Academy of culture in Minsk through cloud signing, and conducted in-depth and extensive communication and exchange on the going out of traditional Chinese medicine enterprises and the internationalization of traditional Chinese medicine. One belt, one road, agreed to actively promote the operation of Pien TSE pharmaceutical in the industrial park of API, including CNAS, certification center and sharing laboratory. At the ceremony, pianzi Huang pharmaceutical donated a batch of anti epidemic traditional Chinese medicine Qingfei Paidu granules to CAMCE international and Zhongbai Industrial Park.

 

Zheng Jiancheng, Secretary of Discipline Inspection Commission of Pianzihuang pharmaceutical, Liu Congsheng, deputy general manager, Liu Jiadan, general manager of Central Asia and Eastern Europe Business Department of CAMCE, Ren Fei, deputy general manager of Zhongbai Industrial Park and Hou Changqing, deputy general manager of China Department, attended the signing ceremony.

 

Pianzihuang pharmaceutical is a national technological innovation demonstration enterprise and a time-honored Chinese enterprise focusing on pharmaceutical manufacturing and R & D, with a market value of nearly 250 billion yuan.

 

Source: Xinhuanet, reference news, official website of Zhongbai Industrial Park, Sina, Tencent, etc

Share

Recommended articles

  • 2021-11-11
      The world's first proprietary Chinese medicine for the treatment of COVID-19 has been released   Zhou Xingting   Yao jian   "Linglan Pesticide-clear" is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park.     The world's first effective Chinese patent medicine for COVID-19 treatment   Southern Guangdong introduced "linglan epidemic qing" registered sales in Australia    On November 5, on the occasion of the opening of the China International Import Expo, the press conference on Traditional Chinese medicine products of the China-Belarus Industrial Park and the signing ceremony of the cooperation agreement of the China-Belarus Industrial Park jointly hosted by the Belarusian Embassy in China, chin...
  • 2021-11-10
      On January 5, Qingfu Capsule, the world's first pure herbal medicine for COVID-19, was jointly developed by China and Belarus and launched in Shanghai. The drug will be produced in the China-Belarus Industrial Park on the outskirts of Minsk, Belarus.   China-belarus Industrial Park Chinese medicine enterprise new era biological medicine company qingfu capsule launch ceremony     Qingfu Capsule is a pure natural plant extract capsule developed and produced by Dr. CAI Chuanqing of Jintai Cultural Institute of China using modern technology combined with traditional medical essence, which can effectively treat and prevent COVID-19. Since February 2020, Linglan granules have successfully cured COVID-19 patients in many countries, including former Ukrainian Prime Minister Yulia Tymoshenko and president Petro Poros...
  • 2021-11-10
      On November 5, when the China International Import Expo opened, the China-Belarus Industrial Park held a press conference on Traditional Chinese medicine products of the Industrial Park and the signing ceremony of the cooperation agreement between the industrial park, demonstrating the major achievements of china-Belarus anti-epidemic cooperation.     According to reports, qingfu capsule series, originated from the classic formula in Treatises on Typhoid fever 1800 years ago, combined with the successful experience of Traditional Chinese medicine in fighting malignant infectious diseases such as The Outbreak of Blast, combined with modern medicine, in view of novel coronavirus characteristics of rapid transmission, rapid disease progression, high mortality and many sequelae, is a new formula. Novel Coronavirus can effectively inhibit novel Coronavirus, redu...